Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial quality control and dynamics machinery is a multi-layered system essential for preserving mitochondrial integrity and cellular homeostasis. It operates through a balance of mitochondrial fission, mediated by proteins like Dynamin-related protein 1 (DRP1), and fusion, governed by Mitofusins (MFN1/2) and Optic atrophy 1 (OPA1) (PubMed). When mitochondria become damaged beyond repair, the machinery initiates mitophagy—a specialized form of autophagy—primarily through the PINK1/Parkin signaling pathway to ensure the removal of dysfunctional organelles (UniProt). Impairment of these regulatory mechanisms is strongly linked to the pathogenesis of neurodegenerative disorders, cardiovascular diseases, and metabolic syndromes, as it leads to the accumulation of defective mitochondria and increased reactive oxygen species (NIH). Pharmacological intervention focuses on modulating these dynamic processes, such as using DRP1 inhibitors to prevent excessive fragmentation or mitophagy enhancers to clear damaged mitochondria, offering a promising therapeutic avenue for age-related and metabolic diseases (Nature Reviews Drug Discovery).
Modulation of mitochondrial fission and fusion proteins (e.g., DRP1 inhibition, MFN activation), induction of mitophagy via PINK1/Parkin or receptor-mediated pathways, and enhancement of mitochondrial proteostasis through chaperone and protease activation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial quality control and dynamics machinery (MQC).